ProfileGDS4718 / 229800_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 38% 45% 80% 24% 51% 14% 18% 36% 66% 52% 44% 49% 19% 9% 21% 62% 63% 23% 20% 20% 50% 65% 43% 63% 40% 28% 49% 21% 42% 7% 20% 44% 47% 23% 29% 29% 16% 72% 28% 87% 41% 17% 53% 13% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.9137138
GSM549102patient 115, normal, homogenized [OPG study]5.2681745
GSM549104patient 119, normal, homogenized [OPG study]7.9774680
GSM549108patient 138, normal, homogenized [OPG study]4.3496424
GSM549119patient 077, normal, homogenized [OPG study]5.5771251
GSM549133patient 032, cancer, homogenized [OPG study]3.894514
GSM549139patient 042, cancer, homogenized [OPG study]4.0580818
GSM549099patient 107, normal, homogenized [OPG study]4.8497836
GSM549109patient 139, normal, homogenized [OPG study]6.5419666
GSM549110patient 046, normal, homogenized [OPG study]5.6229752
GSM549114patient 063, normal, homogenized [OPG study]5.1661544
GSM549122patient 082, normal, homogenized [OPG study]5.4517749
GSM549134patient 033, cancer, homogenized [OPG study]4.1053319
GSM549136patient 036, cancer, homogenized [OPG study]3.702739
GSM549140patient 044, cancer, homogenized [OPG study]4.1320221
GSM549111patient 047, normal, homogenized [OPG study]6.2388462
GSM549113patient 057, normal, homogenized [OPG study]6.2925763
GSM549132patient 031, cancer, homogenized [OPG study]4.2337223
GSM549137patient 038, cancer, homogenized [OPG study]4.1470120
GSM549142patient 047, cancer, homogenized [OPG study]4.2459320
GSM549100patient 110, normal, homogenized [OPG study]5.5238150
GSM549107patient 135, normal, homogenized [OPG study]6.4446665
GSM549115patient 068, normal, homogenized [OPG study]5.0586943
GSM549116patient 072, normal, homogenized [OPG study]6.3401363
GSM549120patient 078, normal, homogenized [OPG study]4.9878340
GSM549131patient 030, cancer, homogenized [OPG study]4.4221228
GSM549118patient 074, normal, homogenized [OPG study]5.4688649
GSM549129patient 027, cancer, homogenized [OPG study]4.2033621
GSM549123patient 088, normal, homogenized [OPG study]5.0662642
GSM549124patient 006, cancer, homogenized [OPG study]3.703187
GSM549126patient 015, cancer, homogenized [OPG study]4.1242220
GSM549128patient 025, cancer, homogenized [OPG study]5.1799644
GSM549103patient 117, normal, homogenized [OPG study]5.3817947
GSM549117patient 073, normal, homogenized [OPG study]4.2389523
GSM549138patient 041, cancer, homogenized [OPG study]4.481629
GSM549141patient 045, cancer, homogenized [OPG study]4.4163229
GSM549130patient 028, cancer, homogenized [OPG study]4.0142716
GSM549101patient 111, normal, homogenized [OPG study]7.0473572
GSM549105patient 128, normal, homogenized [OPG study]4.4749728
GSM549106patient 134, normal, homogenized [OPG study]8.8696787
GSM549112patient 048, normal, homogenized [OPG study]5.0218841
GSM549125patient 011, cancer, homogenized [OPG study]4.0362917
GSM549127patient 024, cancer, homogenized [OPG study]5.6933953
GSM549135patient 035, cancer, homogenized [OPG study]3.836413